Chemotherapy Infusion Reaction and Extravasation Case Lab
Key Takeaways
- Differentiate infusion reaction symptoms from expected adverse effects and respond immediately using institutional protocols.
- Stop the infusion first for suspected hypersensitivity or extravasation, then assess, maintain IV access as appropriate, and notify the provider.
- Extravasation management depends on drug type, site assessment, aspiration, antidote availability, limb care, and documentation.
- Use safe handling precautions for hazardous drugs, contaminated supplies, spills, body fluids, and patient teaching.
- Reassess vital signs, symptoms, IV site, response to interventions, and readiness for rechallenge or transfer.
Case Lab: Chemotherapy Infusion Reaction And Extravasation
Case Snapshot
A 61-year-old patient is receiving cycle 1 of paclitaxel after premedication. Ten minutes into the infusion, the patient reports chest tightness, flushing, shortness of breath, and back pain. The nurse also notices redness near a peripheral IV used earlier for a vesicant chemotherapy push in another patient scenario. These paired problems require quick recognition: infusion reaction and possible extravasation.
First Priorities
For a suspected infusion reaction, stop the infusion immediately. Maintain IV access with normal saline according to policy, assess airway, breathing, circulation, vital signs, oxygen saturation, skin findings, pain, mental status, and symptom onset. Call for help and notify the provider. Administer emergency medications only as ordered by standing protocol or provider order, such as oxygen, antihistamine, corticosteroid, bronchodilator, epinephrine, or fluids. Do not restart the drug unless the provider directs a rechallenge and the patient has stabilized.
| Finding | Likely Concern | Immediate RN Response |
|---|---|---|
| Dyspnea, wheeze, hypotension, throat tightness | Severe hypersensitivity or anaphylaxis | Stop infusion, call for help, oxygen, emergency protocol, provider notification |
| Flushing, mild rash, back pain, stable vitals | Infusion reaction | Stop infusion, assess, medicate per protocol, reassess before any restart |
| Burning, swelling, coolness, no blood return | Extravasation or infiltration | Stop infusion, leave catheter initially if vesicant, aspirate per policy, notify provider |
| Finding | Likely Concern | Immediate RN Response |
|---|---|---|
| Anxiety alone with stable assessment | Distress or mild reaction | Assess carefully; do not dismiss symptoms without objective reassessment |
Extravasation Recognition
Extravasation is leakage of a vesicant or irritant into tissue. It can cause pain, blistering, necrosis, functional injury, and delayed tissue loss. The OCN nurse watches for burning, stinging, swelling, tightness, blanching, erythema, coolness, damp dressing, slowed infusion, or absent blood return. A central line can also extravasate, especially with catheter migration, rupture, or port needle dislodgement.
When suspected, stop the infusion. For vesicants, leave the catheter or needle in place until aspiration is attempted if policy directs it. Do not flush the line because flushing may push more drug into tissue. Notify the provider, identify the drug, estimate the amount, mark and photograph the area per policy, measure the site, and prepare antidote or compress instructions based on the agent. Some agents require cold compresses to limit spread; others require warmth to disperse the drug. The nurse follows the institutional extravasation algorithm rather than relying on memory.
Safe Handling
Hazardous drug safety is part of every infusion case. The nurse uses appropriate personal protective equipment for preparation, administration, disposal, spill response, and contaminated body fluids according to policy. Tubing should be primed safely, connections secured, closed-system devices used when required, and waste placed in the correct containers. Pregnant staff or staff trying to conceive should follow institutional guidance for hazardous drug exposure.
Patient education includes home precautions after hazardous drug therapy. Teach patients and caregivers how long to use gloves for contaminated body fluids based on agency policy, how to handle soiled linens, what to do for spills, when to call for fever or severe symptoms, and why oral chemotherapy must be stored and handled safely. Oral chemotherapy is not casual medication; adherence, missed doses, drug interactions, and safe storage must be reviewed.
Rechallenge And Escalation
After an infusion reaction, the nurse reassesses vital signs, oxygen need, lung sounds, skin, pain, and patient report at frequent intervals. Rechallenge decisions belong to the prescribing provider and protocol. If restarted, the rate may be slower and monitoring more frequent. Worsening symptoms, hypotension, airway symptoms, chest pain, or recurrent reaction require stopping again and urgent escalation.
Documentation
Document time of onset, drug, dose, rate, sequence of symptoms, objective findings, vital signs, IV site assessment, actions taken, medications administered, provider notification, patient response, education, and follow-up instructions. For extravasation, include site measurements, photographs if required, estimated volume, catheter status, aspiration attempt, antidote, compress type, limb instructions, and reassessment plan. In OCN-style questions, the best answer is often the one that stops exposure, assesses severity, follows protocol, escalates appropriately, and documents objective reassessment.
A patient develops dyspnea, flushing, chest tightness, and back pain shortly after paclitaxel starts. What should the nurse do first?
A vesicant extravasation is suspected through a peripheral IV. Which action is unsafe?
Which documentation is most complete after an infusion reaction?